Obesity and Vitamin D Deficiency: Trends to Promote a More Proatherogenic Cardiometabolic Risk Profile

Angiology

Volumn 66, Issue 3, 2015, Pages 237-243

  Stokić, Edita ^a   Kupusinac, Aleksandar ^b   Tomić Naglić, Dragana ^a   Zavišić, Branka Kovačev ^a   Mitrović, Milena ^a   Smiljenić, Dragana ^b   Soskić, Sanja ^c   Isenović, Esma ^c  

^a Clinical Centre of Vojvodina   (Serbia)

^b UNIVERSITY OF NOVI SAD   (Serbia)

^c UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Cardiometabolic risk; Obesity; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; INSULIN; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; LIPID; VITAMIN D;

ADULT; ANTHROPOMETRY; ARTICLE; BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; OBESITY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; ANALYSIS; ATHEROSCLEROSIS; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTOR; SERBIA;

ADIPOSITY; ADULT; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; CASE-CONTROL STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; PREVALENCE; RISK FACTORS; SERBIA; VITAMIN D; VITAMIN D DEFICIENCY; WAIST CIRCUMFERENCE;

EID: 84900801924     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714528569     Document Type: Article

References (51)

1. Tsigos C, Hainer V, Basdevant A, et al.Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008; 1(2):106-116.
2. Grujic V, Dragnic N, Radic I, Harhaji S, Susnjevic S. Overweight and obesity among adults in Serbia: results from the national health survey. Eat Weight Disord. 2010;15(1-2):e34-e42.
3. Must A, Spadano J, Coakley EH, Field AE, Colditz G, DietzWH. The disease burden associated with overweight and obesity. JAMA. 1999;282(16):1523-1529.
4. National Institutes of Health. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults-The Evidence Report. Bethesda MD: NIH publication; 1998.
5. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Characteristics other than the diagnostic criteria associated with metabolic syndrome: an overview. Curr Vasc Pharmacol. 2014; 12(4):627-641.
6. Kienreich K, Tomaschitz A, Verheyen N, et al. Vitamin D and cardiovascular disease. Nutrients. 2013;5(8):3005-3021.
7. Abu El Maaty MA, Hassanein SI, Hanafi RS, Gad MZ. Insights on vitamin D's role in cardiovascular disease: investigating the association of 25-hydroxyvitamin D with the dimethylated arginines. J Nutr Sci Vitaminol (Tokyo). 2013;59(3):172-177.
8. Siadat ZD, Kiani K, Sadeghi M, Shariat AS, Farajzadegan Z, Kheirmand M. Association of vitamin D deficiency and coronary artery disease with cardiovascular risk factors. J Res Med Sci. 2012;17(11):1052-1055.
9. Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension. 2008;52(5):828-832.
10. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proc Nutr Soc. 2013;72(1): 89-97.
11. Ford ES, Ajani UA, Mcguire LC, Liu S. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Diabetes Care. 2005;28(5):1228-1230.
12. Hypponen E, Boucher BJ, Berry DJ, Power C, 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a crosssectional study in the 1958 British birth cohort. Diabetes. 2008; 57(2):298-305.
13. Cimbek A, Gursoy G, Kirnap NG, et al. Relation of obesity with serum 25 hydroxy vitamin D3 levels in type 2 diabetic patients. J Res Med Sci. 2012;17(12):1119-1123.
14. Hossein-Nezhad A, Holick MF. Vitamin D for health: a global perspective. Mayo Clin Proc. 2013;88(7):720-755.
15. Manchanda PK, Bid HK. Vitamin D receptor and type 2 diabetes mellitus: growing therapeutic opportunities. Indian J Hum Genet. 2012;18(3):274-275.
16. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3): 266-281.
17. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-825.
18. Heaney RP, French CB, Nguyen S, et al. A novel approach localizes the association of vitamin D status with insulin resistance to one region of the 25-hydroxyvitamin D continuum. Adv Nutr. 2013;4(3):303-310.
19. Schottker B, Herder C, Rothenbacher D, Perna L,Muller H, Brenner H. Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2: a competing risk analysis in a large populationbased cohort of older adults. Eur J Epidemiol. 2013;28(3):267-275.
20. Hutchinson MS, Figenschau Y, Almas B, Njolstad I, Jorde R. Serum 25-hydroxyvitamin D levels in subjects with reduced glucose tolerance and type 2 diabetes-the Tromso OGTT-study. Int J Vitam Nutr Res. 2011;81(5):317-327.
21. Nazarian S, St Peter JV, Boston RC, Jones SA, Mariash CN. Vitamin D3 supplementation improves insulin sensitivity in subjects with impaired fasting glucose. Transl Res. 2011;158(5):276-281.
22. Liel Y, Ulmer E, Shary J, Hollis BW, Bell NH. Low circulating vitamin D in obesity. Calcif Tissue Int. 1988;43(4):199-201.
23. Hyldstrup L, Andersen T, Mcnair P, Breum L, Transbol I. Bone metabolism in obesity: changes related to severe overweight and dietary weight reduction. Acta Endocrinol (Copenh). 1993; 129(5):393-398.
24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72(3):690-693.
25. Parikh SJ, Edelman M, Uwaifo GI, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004;89(3):1196-1199.
26. Mcgill AT, Stewart JM, Lithander FE, Strik CM, Poppitt SD. Relationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity. Nutr J. 2008;7:1-5.
27. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6): 499-502.
28. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
29. Taheri E, Saedisomeolia A, Djalali M, Qorbani M, Madani Civi M. The relationship between serum 25-hydroxy vitamin D concentration and obesity in type 2 diabetic patients and healthy subjects. J Diabetes Metab Disord. 2012;11(1):16.
30. De Pergola G, Nitti A, Bartolomeo N, et al. Possible role of hyperinsulinemia and insulin resistance in lower vitamin D levels in overweight and obese patients. Biomed Res Int. 2013;2013:921348.
31. Buffington C, Walker B, Cowan GS Jr, Scruggs D. Vitamin D deficiency in the morbidly obese. Obes Surg. 1993;3(4):421-424.
32. Hey H, Stokholm KH, Lund B, Lund B, Sorensen OH. Vitamin D deficiency in obese patients and changes in circulating vitamin D metabolites following jejunoileal bypass. Int J Obes. 1982;6(5): 473-479.
33. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003;88(1):157-161.
34. Salekzamani S, Neyestani TR, Alavi-Majd H, et al. Is vitamin D status a determining factor for metabolic syndrome? A casecontrol study. Diabetes Metab Syndr Obes. 2011;4:205-212.
35. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80(6 suppl):1678S-1688S.
36. Sneve M, Figenschau Y, Jorde R. Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol. 2008;159(6):675-684.
37. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, Balsa JA, Vazquez C, Escobar-Morreale HF. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr. 2007;26(5):573-580.
38. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009;6(10):621-630.
39. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-results from a randomized trial. Eur J Intern Med. 2013;24(7):644-649.
40. Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr. 2007;85(1):54-59.
41. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes. 2010;59(1):242-248.
42. Tai K, Need AG, Horowitz M, Chapman IM. Vitamin D, glucose, insulin, and insulin sensitivity. Nutrition. 2008; 24(3):279-285.
43. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab. 2007;92(6):2017-2029.
44. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008;168(12):1340-1349.
45. Reis JP, Von Muhlen D, Miller ER 3 rd, Michos ED, Appel LJ. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics. 2009;124(3): e371-e379.
46. Poole KE, Loveridge N, Barker PJ, et al. Reduced vitamin D in acute stroke. Stroke. 2006;37(1):243-245.
47. Katsiki N, Athyros VG, Karagiannis A, Mikhailidis DP. Vitamin D deficiency, statin-related myopathy and other links with vascular risk. Curr Med Res Opin. 2011;27(9):1691-1692.
48. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008;168(11):1174-1180.
49. Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117(4):503-511.
50. De Lorenzo A, Martinoli R, Vaia F, Di Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis. 2006;16(8):513-523.
51. García-Bailo B, Da Costa LA, Arora P, Karmali M, El-Sohemy A, Badawi A. Plasma vitamin D and biomarkers of cardiometabolic disease risk in adult Canadians, 2007-2009. Prev Chronic Dis. 2013;10:E91.